EGEnrique Ginzburg

Enrique Ginzburg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Enrique Ginzburg has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Do statins reduce rates of venous thromboembolism in high-risk trauma patients?

    by Jessica M. Delamater, Michael D. Cobler-Lichter, Timothy Ko, Talia R. Arcieri, Ana M. Reyes, Nicholas H. Carter, Louis Pizano, Enrique Ginzburg, Nicholas Namias, Jonathan P. Meizoso, et al.

    BACKGROUND: The risk of venous thromboembolism (VTE) in subsets of the most severely injured patients can approach 30%. Statins have anti-inflammatory properties and exert beneficial effects on the endothelium, but few previous studies have evaluated their effects on VTE in risk-stratified groups. We hypothesized that statin use was associated with lower VTE in high-risk trauma patients. METHODS: All patients admitted to the trauma intensive care unit (ICU) from 1/2024 to 11/2024 at a single level 1 trauma center were risk-stratified using the Greenfield Risk Assessment Profile (RAP). Nontrauma patients and burn patients were excluded. Outcomes were compared between patients with and without VTE, defined by deep vein thrombosis or pulmonary embolism. Univariate analyses and multivariate logistic regression evaluated the association between statin use and VTE. Statistical significance was assessed at p ≤0.05. RESULTS: In 509 patients (age 52±22 y, 71% male, 18% penetrating injury), the average RAP score was 10±5, the overall VTE rate was 17%, and mortality was 5%. Compared with statin nonusers, statin users (n=100) were older, with more blunt injury, similar RAP scores and thromboprophylaxis use, but had a significantly lower VTE rate (8 vs. 19%, P =0.007). After RAP-based stratification, the high-risk group (RAP≥10) had a VTE rate of 28%. After controlling for confounding variables with multivariate logistic regression, statin use was independently associated with decreased VTE with an odds ratio of 0.209 (95% CI: 0.065-0.670, P =0.008). CONCLUSIONS: Severely injured patients have high rates of VTE despite thromboprophylaxis;, however, the incidence of VTE was significantly lower among statin users. In the highest risk patients, statin use was independently associated with decreased odds of VTE. Because of their pleiotropic effects, including anti-inflammatory and endothelial protective properties, statins may be an important adjunctive therapy in VTE chemoprophylaxis. ( J Trauma Acute Care Surg . 2026;00: 000–000 Copyright © 2026 Wolters Kluwer Health, LLC. All rights reserved.) LEVEL OF EVIDENCE: Level III, therapeutic/care management.

  • Open Access

    Miami-Dade County Juvenile Weapons Offenders Program (JWOP): a potential model to reduce firearm crime recidivism nationwide

    by Hahn Soe-Lin, Anjali Sarver, Joyce Kaufman, Marilyn Sutherland, Enrique Ginzburg

    Introduction Youth firearm violence has been a growing problem in the USA. Several programs across the country aimed at reducing recurrent gun violence in this vulnerable population have published recidivism rates of 40% to 50%. For the past 18 years, the Juvenile Weapons Offenders Program (JWOP) in Miami-Dade County has provided a unique multidisciplinary intervention encompassing 100 hours of violence education, behavioral modification, and social mentoring. The present study defines its outcomes as a national model for youth firearm recidivism prevention. Methods Retrospective analysis of Florida Juvenile Justice Department records from 2008 to 2016 defined a group of youths convicted of firearm-related crimes and subsequently enrolled in the program. Cohorts were those who demonstrated successful completion of the JWOP program versus those who partially completed the program. At 6 and 12 months after release, records were cross-referenced with Florida Department of Justice criminal record system to prospectively capture rates of new all-comer and firearm-specific criminal charges. Results 215 youth were included in the prospectively followed cohort at 6 months and 163 youth followed at 12 months after release. The 6-month recidivism rate for any criminal charge was 20.1% for program completers versus 32.9% for those who did not complete the program (p=0.047). When excluding unarmed criminal offenses, the recidivism rate dropped to 10.1% versus 22.4%, respectively (p=0.008). At 12 months, all-comers recidivism was 33.6% for the GATE program completion cohort versus 50% for the incomplete cohort (p=0.045). When excluding unarmed offenses, the recidivism rates were 18.6% versus 33.9%, respectively (p=0.035). Conclusion The JWOP program has one of the lowest recidivism rates for reoffense for firearm and non-firearm-related offenses. Further investigation into details of the program’s efficacy and its applicability for expansion to other state and national jurisdictions should serve a model for decreasing youth gun violence across the country.


  • Open Access

    Testosterone and growth hormone normalization: a retrospective study of health outcomes

    by Julie Holt, Enrique Ginzburg, Alvin Lin, Michael Sigler, Denise Olsen, Nancy Klimas, Alan Mintz

    Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articlesor submit your research for publishing